Health
‘Significant humoral response’ following two COVID-19 vaccine doses in RMD patients – medwireNews
Most patients with rheumatic and musculoskeletal diseases mount a humoral immune response following receipt of the second dose……
medwireNews: Most patients with rheumatic and musculoskeletal diseases (RMDs) mount a humoral immune response following receipt of the second dose of the PfizerBioNTech (BNT162b2) vaccine against SARS-CoV-2, say researchers.
Yolanda Braun-Moscovici (Rambam…
Continue Reading
